This increment, mainly due to the 34-kDa glycoform of apoE, which is likely hypo-sialylated, and the appearance of a β-mercaptoethanol-resistant 100-kDa apoE species, could indicate that the ability of apoE in AD to achieve its biological functions may be compromised. This evidence concerns the gene APOE and Alzheimer disease.